Stock Transactions (Details Narrative) (USD $)	1 Months Ended
	Mar. 26, 2015	Mar. 23, 2015	Mar. 17, 2015	Mar. 06, 2015	Feb. 27, 2015	Feb. 13, 2015	Feb. 10, 2015
Notes to Financial Statements
Common stock issued in satisfaction of convertible debt					200,000,000		103,030,303
Amount of convertible debt satisfied					$ 20,000		$ 17,000
Regen Biopharma common stock issued to CEO as Restricted Stock Award						9,000,000
Regen Biopharma common stock issued to CFO as Restricted Stock Award						7,500,000
Regen Biopharma common stock issued to CSO as Restricted Stock Award						6,000,000
Regen Biopharma common shares issued for conversion of debt				19,932,520
Amount of debt converted				557,686
Regen Biopharma common shares issued for consulting services				500,000
Value of consulting services				140,000
Fair value of CFO consulting services				63,737
Total common shares issued for debt conversions	11,606,742
Total debt converted	325,000
Regen Biopharma Series A preferred stock issued for convertible debt			26,181,719
Regen Biopharma Series A stock issued to CEO as Restricted Stock Award			2,500,000
Regen Biopharma Series A stock issued to CFO as Restricted Stock Award			2,500,000
Regen Biopharma Series A stock issued to CSO as Restricted Stock Award			2,500,000
Regen Biopharma Series A stock issued to employee as Restricted Stock Award			2,500,000
Regen Biopharma Series A stock issued for consulting services			4,200,000
Regen Biopharma Series AA preferred stock issued for debt		20,000				10,000
Amount of debt satisfied		$ 4,000				$ 2,000